DMAE is a memory enhancing substance common to a number of drugs that are known to stabilize cell membranes. Cell membrane degradation has been proposed as one of the prime mechanisms of aging. DMAE is a precursor to choline and acetylcholine. However, DMAE has been shown to cross the blood-brain barrier faster than choline. It is the choline inside cells that is converted to phosphatidylcholine, used in the building and repair of cell membranes, especially in the brain.
In Europe, the drug Centrophenoxine, which combines DMAE with a synergistic chemical called p-chlorophenoxyacetate, is prescribed to boost cognitive function in the aged. It is likely that all the benefits of Centrophenoxine may be obtained more inexpensively from DMAE.
GINGKO
For nearly 2800 years the Chinese have used extracts from the ginkgo biloba tree to treat a variety of conditions. The Foundation's ginkgo extract (6% terpene lactone) is prepared from the dried leaves of the ginkgo biloba tree.
Studies published in medical journals show that ginkgo can improve mental function in people of all ages. Some European physicians have stated ginkgo is more effective than high doses of Hydergine in treating senile dementia.
Ingredients:
Ginkgo biloba leaf powder extract 60 mg
standardized to supply:
Ginkgo flavone glycosides (24%) 14.4 mg
Terpene lactones (6%) 3.6 mg
Dimethylaminoethanol Bitartrate (DMAE) 100 mg
Pantothenic acid (vitamin B5) 80 mg
Inositol 25 mg
Thiamin (B1- from thiamin HCL) 10 mg
Riboflavin (vitamin B2) 10 mg
Niacinamide (vitamin B3) 10 mg
Other ingredients: rice flour, magnesium stearate, gelatin and water.
Suggested use: One to two capsules daily are suggested for healthy people. Four capsules daily are recommended for those with neural impairment. This product need not be taken at meals.
